Caeli Nova agreement to expand Airbus’ sustainable technology offeringCo-Development Partnership Agreement • September 16th, 2021
London, 21 September 2021: Breathing technology expert Caeli Nova is signing a Co-Development Partnership Agreement with Airbus to enhance technical collaboration on Cordillera, Caeli Nova’s innovative new passenger emergency oxygen system, for use onboard Airbus aircraft.
CO-DEVELOPMENT PARTNERSHIP AGREEMENTCo-Development Partnership Agreement • March 4th, 2015 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • Delaware
This CO-DEVELOPMENT PARTNERSHIP AGREEMENT (“Agreement”) is entered into on February 3, 2015 (the “Effective Date”) by and between T2 BIOSYSTEMS INC., a Delaware corporation (“T2 Bio”), having its principal offices at 101 Hartwell Avenue, Lexington, Massachusetts 02421, and CANON U.S. LIFE SCIENCES, INC., a Delaware corporation (“Canon US Life Sciences”), having its principal offices at 9800 Medical Center Drive, Rockville, MD 20850, and any other Affiliates of Canon US Life Sciences that the Parties agree in writing to add to this Agreement (together with Canon US Life Sciences, “Canon”). T2 Bio and Canon are each a “Party” and together the “Parties” to this Agreement.
